Literature DB >> 6572529

Use of prostaglandin E2 in management of transposition of great arteries before balloon atrial septostomy.

A Beitzke, C H Suppan.   

Abstract

Fifteen infants with transposition of the great arteries and severe hypoxaemia were treated with prostaglandin E2 infusions before atrial septostomy was performed. Twelve patients had simple transposition and three had small ventricular septal defects. The infusion resulted in a highly significant increase of PaO2 from 22 +/- 3 mmHg to 37 +/- 5 mmHg within one to two hours. Only one patient did not respond to treatment. PaO2 remained constantly above 30 mmHg throughout prostaglandin infusion. After balloon atrial septostomy prostaglandin administration was stopped. Only two patients required reinfusion within 24 hours after septostomy because of a decrease of PaO2 below 25 mmHg. At angiocardiography before balloon septostomy the ductus was of aortic size in eight, and of about half the aortic diameter in six patients. In one infant the ductus was closed. One infant had to undergo early ductus ligation because of heart failure. In 10 of 11 infants who have undergone total correction the initially large ductus had closed spontaneously.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6572529      PMCID: PMC481310          DOI: 10.1136/hrt.49.4.341

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  Persistence of the fetal pattern of circulation in transposition of the great arteries.

Authors:  R E Hawker; R M Freedom; R D Rowe; L J Krovetz
Journal:  Johns Hopkins Med J       Date:  1974-02

2.  The use of prostaglandin E1 in a critically ill infant with transposition of the great arteries.

Authors:  D J Driscoll; J D Kugler; M R Nihill; D G McNamara
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

3.  Factors influencing intercirculatory mixing in patients with complete transposition of the great arteries.

Authors:  D D Mair; D G Ritter
Journal:  Am J Cardiol       Date:  1972-11-08       Impact factor: 2.778

4.  Treatment of d-transposition of the great arteries: management of hypoxemia after balloon atrial septostomy.

Authors:  C G Henry; D Goldring; A F Hartmann; C S Weldon; A W Strauss
Journal:  Am J Cardiol       Date:  1981-02       Impact factor: 2.778

5.  Long-term low-dose prostaglandin E1 administration.

Authors:  P Pitlick; J W French; A Maze; K J Kimble; R L Ariagno; B A Reitz
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

6.  Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.

Authors:  M D Freed; M A Heymann; A B Lewis; S L Roehl; R C Kensey
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

7.  Role of prostaglandin E1 infusion in the management of transposition of the great arteries.

Authors:  L N Benson; P M Olley; R G Patel; F Coceani; R D Rowe
Journal:  Am J Cardiol       Date:  1979-10       Impact factor: 2.778

8.  Reliability of capillary blood for the measurement of pO2 and O2 saturation.

Authors:  S J Stamm
Journal:  Dis Chest       Date:  1967-08

9.  Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.

Authors:  A B Lewis; M D Freed; M A Heymann; S L Roehl; R C Kensey
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

10.  Use of prostaglandin E1 in infants with d-transposition of the great arteries and intact ventricular septum.

Authors:  P Lang; M D Freed; F Z Bierman; W I Norwood; A S Nadas
Journal:  Am J Cardiol       Date:  1979-07       Impact factor: 2.778

View more
  8 in total

1.  Effect of prostaglandin duration on outcomes in transposition of the great arteries with intact ventricular septum.

Authors:  Ryan J Butts; Alexander R Ellis; Scott M Bradley; Thomas C Hulsey; Andrew M Atz
Journal:  Congenit Heart Dis       Date:  2012-02-23       Impact factor: 2.007

Review 2.  Blue babies: when to intervene.

Authors:  Savitri Shrivastava
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

3.  Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease.

Authors:  B D Thanopoulos; A Andreou; C Frimas
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

4.  Prostaglandin E2 after septostomy for simple transposition.

Authors:  Lynne Mary Beattie; Karen A McLeod
Journal:  Pediatr Cardiol       Date:  2008-12-16       Impact factor: 1.655

5.  Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease.

Authors:  H H Kramer; M Sommer; S Rammos; O Krogmann
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

6.  Prostaglandin E1 in suspected ductus dependent cardiac malformation.

Authors:  K A Hallidie-Smith
Journal:  Arch Dis Child       Date:  1984-11       Impact factor: 3.791

7.  Responsiveness of the ductus arteriosus to prostaglandin E1 assessed by combined cross sectional and pulsed Doppler echocardiography.

Authors:  S Hiraishi; N Fujino; K Saito; K Oguchi; N Kadoi; Y Agata; Y Horiguchi; H Hozumi; K Yashiro
Journal:  Br Heart J       Date:  1989-08

Review 8.  Timing of surgery/catheter intervention in common congenital cardiac defects.

Authors:  S Shrivastava
Journal:  Indian J Pediatr       Date:  2000-04       Impact factor: 1.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.